|what new drug looks soon to hit approval for salvage patients
Jul 21, 2008
I hope you are doing well in health! You are such an inspiration. Since you made the salvage therapies sight- i was wondering what drug or drugs look closing to making it possibly to approval in 2008 for salvage patients like myself. Thank you. You are a true hero and inspiration.
| Response from Mr. Vergel
Like you, I am a "salvage" patient with multi-drug resistance looking for the best new drug.
We are starting a "dry period" in HIV drug approvals that will last around 3 years, so for those of us who have failed Fuzeon, raltegravir and have X4 tropic virus, very few drug will be coming our way. Tanox, a company that was bought out by Genetech, has an I.V. drug (a monoclonal antibody) that will start phase II studies in a few weeks. That is about all we have as a new agent for multi-drug resistant virus.
As you know, we just went through a wave of new drug approvals last year. Raltegravir, maraviroc and TMC-125 (a non-nuke) were approved. But a few patients already have raltegravir resistance. Our main job as activists is to remind companies that we exist and that there will be a need for better drugs in the future.
I am following gene therapy and stem cell research as a true hope to change the nature of how we treat HIV.
I hope you do not have raltegravir resistance and that your tropism test showed an R5 virus.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.